Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2000;31:2971-2975

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Faßbender, K.
Right arrow Articles by Hennerici, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faßbender, K.
Right arrow Articles by Hennerici, M.
Related Collections
Right arrow Ischemic biology - basic studies
Right arrow Intracerebral Hemorrhage
Right arrow Neuroprotectors
Right arrow Endothelium/vascular type/nitric oxide

(Stroke. 2000;31:2971.)
© 2000 American Heart Association, Inc.


Original Contributions

Endothelin-1 in Subarachnoid Hemorrhage

An Acute-Phase Reactant Produced by Cerebrospinal Fluid Leukocytes

Klaus Faßbender, MD; Britta Hodapp; Siegbert Rossol, MD; Thomas Bertsch, MD; Joachim Schmeck, MD; Sandra Schütt, MD; Michael Fritzinger, MD; Peter Horn, MD; Peter Vajkoczy, MD; Martina Wendel-Wellner; Andreas Ragoschke, MD; Sandra Kuehl, PhD; Jürgen Brunner, MD; Ludwig Schürer, MD; Peter Schmiedeck, MD Michael Hennerici, MD

From the Departments of Neurology (K.F., B.H., M.F., A.R., S.K., M.H.), Internal Medicine (S.R.), Clinical Chemistry (T.B.), Anesthesiology (J.S., M.W.-W.), and Neurosurgery (S.S., P.H., P.V., J.B., L.S., P.S.), Clinic Mannheim, University of Heidelberg, Heidelberg, Germany.

Correspondence to Klaus Faßbender, MD, Department of Neurology, Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer, 68135 Mannheim, FRG. E-mail Fass{at}neuro.ma.uni-heidelberg.de

Background and Purpose—The most potent vasoconstrictor known, endothelin-1, is currently considered to mediate cerebral vasospasm in subarachnoid hemorrhage (SAH), which can cause delayed cerebral ischemia. In our study, we performed clinical and in vitro experiments to investigate the origin and the mechanisms of the secretion of endothelin-1 in SAH.

Methods—Endothelin-1 and markers of inflammatory host response (interleukin [IL]-1ß, IL-6, and tumor necrosis factor-{alpha}) were comparatively quantified in the cerebrospinal fluid (CSF) of SAH patients and control subjects, and concentrations were related to clinical characteristics. Furthermore, mononuclear leukocytes isolated from the CSF of SAH patients and control subjects were analyzed regarding their mRNA expression of endothelin-1 and inflammatory cytokines. Finally, complementary in vitro experiments were performed to investigate whether coincubation of blood and CSF can trigger leukocytic mRNA expression and release of these factors.

Results—Activated mononuclear leukocytes in the CSF of SAH patients synthesize and release endothelin-1 in parallel with known acute-phase reactants (IL-1ß, IL-6, and tumor necrosis factor-{alpha}). Complementary in vitro experiments not only further confirmed this leukocytic origin of endothelin-1 but also showed that aging and subsequent hemolysis of blood is sufficient to induce such endothelin-1 production.

Conclusions—The demonstration that endothelin-1 is produced by activated CSF mononuclear leukocytes suggests that subarachnoid inflammation may represent a therapeutic target to prevent vasospasm and delayed cerebral ischemia after SAH.


Key Words: cerebral ischemia • cytokines • endothelins • subarachnoid hemorrhage • vasospasm




This article has been cited by other articles:


Home page
StrokeHome page
H. Yatsushige, M. Yamaguchi, C. Zhou, J. W. Calvert, and J. H. Zhang
Role of c-Jun N-Terminal Kinase in Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage
Stroke, July 1, 2005; 36(7): 1538 - 1543.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Kay, A. Petzold, M. Kerr, G. Keir, E. Thompson, and J. Nicoll
Decreased Cerebrospinal Fluid Apolipoprotein E After Subarachnoid Hemorrhage: Correlation With Injury Severity and Clinical Outcome
Stroke, March 1, 2003; 34(3): 637 - 642.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C.J.M. Frijns and L.J. Kappelle
Inflammatory Cell Adhesion Molecules in Ischemic Cerebrovascular Disease
Stroke, August 1, 2002; 33(8): 2115 - 2122.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Tosaka, F. Okajima, Y. Hashiba, N. Saito, T. Nagano, T. Watanabe, T. Kimura, and T. Sasaki
Sphingosine 1-Phosphate Contracts Canine Basilar Arteries In Vitro and In Vivo: Possible Role in Pathogenesis of Cerebral Vasospasm
Stroke, December 1, 2001; 32(12): 2913 - 2919.
[Abstract] [Full Text] [PDF]